ESR1 and breast cancer: ADAMTS-1 expression decreased in human breast tumors in vivo, mainly in triple negative cases (ER-, PR-, and Her-2), and ADAMTS-1 knockdown was shown to stimulate migration, invasion and invadopodia formation in breast cancer cells in vitro.